Correlation Between Unicycive Therapeutics and Adagene

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Adagene, you can compare the effects of market volatilities on Unicycive Therapeutics and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Adagene.

Diversification Opportunities for Unicycive Therapeutics and Adagene

0.15

Correlation Coefficient

Unicycive Therapeutics  Adagene

Average diversification

The 3 months correlation between Unicycive and Adagene is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Adagene go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Adagene

Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the Adagene. In addition to that, Unicycive Therapeutics is 1.32 times more volatile than Adagene. It trades about -0.08 of its total potential returns per unit of risk. Adagene is currently generating about -0.1 per unit of volatility. If you would invest  201.00  in Adagene on December 29, 2024 and sell it today you would lose (45.00) from holding Adagene or give up 22.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  Adagene

Unicycive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Unicycive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Adagene

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Unicycive Therapeutics and Adagene

The main advantage of trading using opposite Unicycive Therapeutics and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.

The idea behind Unicycive Therapeutics and Adagene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.